DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TAPOTOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Multiple Myeloma
Unknown
TAPOTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
97W7N9T08G
Molecule Type:
Small molecule
Molecular Formula:
C33H41ClN2O5S
Molecular Weight:
613.22
AlogP:
5.9
PSA:
84.94
HBD:
1.0
HBA:
#RotB:
1.0
Source:
METHANESULFONYL FLUORIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHANESULFONYL FLUORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
9H250YYY0R
Molecule Type:
Small molecule
Molecular Formula:
CH3FO2S
Molecular Weight:
98.1
AlogP:
-0.08
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
0.0
Source:
PF-05180999
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders; Schizophrenia
Unknown
PF-05180999
×
Maximum Phase:
1
First Approval:
None
UNII:
5L84K4IEN9
Molecule Type:
Small molecule
Molecular Formula:
C19H17F3N8
Molecular Weight:
414.4
AlogP:
3.12
PSA:
77.03
HBD:
0.0
HBA:
#RotB:
3.0
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PLX-7486
1
Small molecule
Investigational
Unknown
Unknown
Synovitis, Pigmented Villonodular
Macrophage colony stimulating factor receptor inhibitor
PLX-7486
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLOCROLIMUS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
FK506-binding protein 1A inhibitor
OLOCROLIMUS
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAY-1082439
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
PI3-kinase p110-alpha subunit inhibitor
BAY-1082439
×
Maximum Phase:
1
First Approval:
None
UNII:
59784ZX4GD
Molecule Type:
Small molecule
Molecular Formula:
C25H30N6O5
Molecular Weight:
494.55
AlogP:
0.96
PSA:
121.11
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
FRUCTOSE
1
Small molecule
Investigational
Unknown
Unknown
Hypoglycemia; Melanoma; Non-alcoholic Fatty Liver Disease; Obesity
Unknown
FRUCTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
6YSS42VSEV
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
TEGLARINAD CHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Nicotinamide phosphoribosyltransferase inhibitor
TEGLARINAD CHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
D6V5QYX9MZ
Molecule Type:
Small molecule
Molecular Formula:
C30H43Cl2N5O8
Molecular Weight:
672.61
AlogP:
3.91
PSA:
145.77
HBD:
2.0
HBA:
#RotB:
23.0
Source:
PF-04455242
1
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Depressive Disorder
Unknown
PF-04455242
×
Maximum Phase:
1
First Approval:
None
UNII:
Y3530Z78QD
Molecule Type:
Small molecule
Molecular Formula:
C21H28N2O2S
Molecular Weight:
372.53
AlogP:
3.88
PSA:
49.41
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
BIAPENEM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
BIAPENEM
×
Maximum Phase:
1
First Approval:
None
UNII:
YR5U3L9ZH1
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O4S
Molecular Weight:
350.4
AlogP:
-1.89
PSA:
102.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
E-2212
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
E-2212
×
Maximum Phase:
1
First Approval:
None
UNII:
V9KGF25853
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N6O
Molecular Weight:
480.49
AlogP:
5.29
PSA:
70.65
HBD:
0.0
HBA:
#RotB:
5.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GMI-1271
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GMI-1271
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARRY-300
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
ARRY-300
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CPP-115
1
Small molecule
Investigational
Unknown
Unknown
Cocaine-Related Disorders
Unknown
CPP-115
×
Maximum Phase:
1
First Approval:
None
UNII:
0285I2MVUA
Molecule Type:
Small molecule
Molecular Formula:
C7H9F2NO2
Molecular Weight:
177.15
AlogP:
0.96
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MAFOSFAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia; Lymphoma; Meningeal Neoplasms
Unknown
MAFOSFAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
5970HH9923
Molecule Type:
Small molecule
Molecular Formula:
C9H19Cl2N2O5PS2
Molecular Weight:
401.27
AlogP:
1.83
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
HMN-214
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Serine/threonine-protein kinase PLK1 inhibitor
HMN-214
×
Maximum Phase:
1
First Approval:
None
UNII:
94E9UR0RFR
Molecule Type:
Small molecule
Molecular Formula:
C22H20N2O5S
Molecular Weight:
424.48
AlogP:
3.24
PSA:
90.62
HBD:
0.0
HBA:
#RotB:
6.0
Source:
SEVITERONEL
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Breast Neoplasms, Male; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Androgen Receptor antagonist
SEVITERONEL
×
Maximum Phase:
1
First Approval:
None
UNII:
8S5OIN36X4
Molecule Type:
Small molecule
Molecular Formula:
C18H17F4N3O3
Molecular Weight:
399.34
AlogP:
4.05
PSA:
80.26
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VEBRELTINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms
Unknown
VEBRELTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
2WZP8A9VFN
Molecule Type:
Small molecule
Molecular Formula:
C20H15F3N8
Molecular Weight:
424.39
AlogP:
3.49
PSA:
78.72
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TRANSTORINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRANSTORINE
×
Maximum Phase:
1
First Approval:
None
UNII:
H030S2S85J
Molecule Type:
Small molecule
Molecular Formula:
C10H7NO3
Molecular Weight:
189.17
AlogP:
1.23
PSA:
70.16
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MITOQUINOL CATION
1
Small molecule
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
MITOQUINOL CATION
×
Maximum Phase:
1
First Approval:
None
UNII:
65M41NIO61
Molecule Type:
Small molecule
Molecular Formula:
C37H46O4P+
Molecular Weight:
585.75
AlogP:
8.08
PSA:
58.92
HBD:
2.0
HBA:
#RotB:
16.0
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
D6-25-HYDROXYVITAMIN D3
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
D6-25-HYDROXYVITAMIN D3
×
Maximum Phase:
1
First Approval:
None
UNII:
378HY809HV
Molecule Type:
Small molecule
Molecular Formula:
C27H44O2
Molecular Weight:
406.68
AlogP:
6.73
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
6.0
Source:
H-100
1
Small molecule
Investigational
Unknown
Unknown
Penile Induration
Unknown
H-100
×
Maximum Phase:
1
First Approval:
None
UNII:
5RQ73K2EC8
Molecule Type:
Small molecule
Molecular Formula:
C11H11N3O3
Molecular Weight:
233.23
AlogP:
0.44
PSA:
102.22
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BMS-791826
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-791826
×
Maximum Phase:
1
First Approval:
None
UNII:
60BN6CDL0K
Molecule Type:
Small molecule
Molecular Formula:
C28H26FN5O3S
Molecular Weight:
531.61
AlogP:
5.73
PSA:
97.31
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MP-412
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MP-412
×
Maximum Phase:
1
First Approval:
None
UNII:
Z541VW0W40
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FXR-450
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FXR-450
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04418948
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-04418948
×
Maximum Phase:
1
First Approval:
None
UNII:
I7Z38E70VF
Molecule Type:
Small molecule
Molecular Formula:
C23H20FNO5
Molecular Weight:
409.41
AlogP:
3.59
PSA:
76.07
HBD:
1.0
HBA:
#RotB:
6.0
Source:
IT-139
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
IT-139
×
Maximum Phase:
1
First Approval:
None
UNII:
7OSJ9KS483
Molecule Type:
Small molecule
Molecular Formula:
C14H12Cl4N4NaRu
Molecular Weight:
502.15
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
65
66
67
68
69
70
71
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA